EP0977585A4 - Procedes de diagnostic et de traitement de troubles lies au poids corporel chez l'animal - Google Patents

Procedes de diagnostic et de traitement de troubles lies au poids corporel chez l'animal

Info

Publication number
EP0977585A4
EP0977585A4 EP98902655A EP98902655A EP0977585A4 EP 0977585 A4 EP0977585 A4 EP 0977585A4 EP 98902655 A EP98902655 A EP 98902655A EP 98902655 A EP98902655 A EP 98902655A EP 0977585 A4 EP0977585 A4 EP 0977585A4
Authority
EP
European Patent Office
Prior art keywords
diagnosing
animals
methods
body weight
related disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98902655A
Other languages
German (de)
English (en)
Other versions
EP0977585A1 (fr
Inventor
Denisa D Wagner
Zhao Ming Dong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immune Disease Institute Inc
Original Assignee
Immune Disease Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Disease Institute Inc filed Critical Immune Disease Institute Inc
Publication of EP0977585A1 publication Critical patent/EP0977585A1/fr
Publication of EP0977585A4 publication Critical patent/EP0977585A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Child & Adolescent Psychology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP98902655A 1997-01-24 1998-01-22 Procedes de diagnostic et de traitement de troubles lies au poids corporel chez l'animal Withdrawn EP0977585A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3589697P 1997-01-24 1997-01-24
US35896P 1997-01-24
PCT/US1998/001110 WO1998032460A1 (fr) 1997-01-24 1998-01-22 Procedes de diagnostic et de traitement de troubles lies au poids corporel chez l'animal

Publications (2)

Publication Number Publication Date
EP0977585A1 EP0977585A1 (fr) 2000-02-09
EP0977585A4 true EP0977585A4 (fr) 2001-04-11

Family

ID=21885432

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98902655A Withdrawn EP0977585A4 (fr) 1997-01-24 1998-01-22 Procedes de diagnostic et de traitement de troubles lies au poids corporel chez l'animal

Country Status (4)

Country Link
EP (1) EP0977585A4 (fr)
JP (1) JP2001511889A (fr)
CA (1) CA2276691A1 (fr)
WO (1) WO1998032460A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4689787B2 (ja) * 1999-04-12 2011-05-25 住友化学株式会社 腹腔内脂肪組織量の分析方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994011400A1 (fr) * 1992-11-18 1994-05-26 Helsinki University Licensing Ltd. Oy Peptides de icam-2 et icam-1 chez l'homme et leurs analogues s'utilisant en therapie et diagnostic

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284931A (en) * 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
US5223396A (en) * 1991-05-03 1993-06-29 Boehringer Ingelheim Pharmaceuticals, Inc. Method for detecting organ transplant rejection

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994011400A1 (fr) * 1992-11-18 1994-05-26 Helsinki University Licensing Ltd. Oy Peptides de icam-2 et icam-1 chez l'homme et leurs analogues s'utilisant en therapie et diagnostic

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9832460A1 *

Also Published As

Publication number Publication date
CA2276691A1 (fr) 1998-07-30
EP0977585A1 (fr) 2000-02-09
WO1998032460A1 (fr) 1998-07-30
JP2001511889A (ja) 2001-08-14

Similar Documents

Publication Publication Date Title
PL337888A1 (en) Imidazoprimidines and imidazopyridines for use in treating neurological disorders
EP1039834A4 (fr) Agents de contraste optoacoustiques et procedes d'utilisation
EP1019432A4 (fr) Recepteur ob et procedes de diagnostic et de traitement des dereglements de la masse corporelle
EP0701499A4 (fr) Tampons de polissage ameliores et leurs procedes d'utilisation
LV11868A (lv) Kermena svara modulatori to pielietojums diagnostika un terapija
IL139030A0 (en) Therapeutic angiogenic factors and methods for their use
EP1065978A4 (fr) Dispositif therapeutique implantable et methode afferente
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
IL126900A0 (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU5592698A (en) Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein
EP0924983A4 (fr) S(-)-tolterodine pour le traitement des troubles urinaires et gastro-intestinaux
PL331465A1 (en) Novel compounds and agents for treating diseases associated with triptase activity
PL336349A1 (en) Compositions for and methods for treating and diagnosing the mastocarcinoma
GB9809448D0 (en) Treatment device and method
GB9621825D0 (en) Microparticles and their use as therapeutic vehicles
IL129460A0 (en) Use of lofexidine in the treatment of behavioral disorders
EP0977585A4 (fr) Procedes de diagnostic et de traitement de troubles lies au poids corporel chez l'animal
GB9517697D0 (en) Ultrasound bone analysers and methods for sensing body part
IL111228A0 (en) Non-invasive device and method for quantitative determination of oxidants and/or antioxidants in the skin
EP0980261A4 (fr) Methodes de prevention et de traitement du desequilibre metabolique induit par insulte chez les humains et des animaux
EP0872219A4 (fr) Utilisation du spectre de frequences biologiques dans l'embryogenese animale
AU6257998A (en) Methods for diagnosing and treating autoimmune disease
IL113347A (en) Brain endothelial cell protein and methods for its use
GB9410958D0 (en) Ankle and lower body exerciser
EP0691402A3 (fr) ARNs satellites modifiés et virus satellites en tant que support de ribozymes adaptés

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990824

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: DONG, ZHAO, MING

Inventor name: WAGNER, DENISA, D.

A4 Supplementary search report drawn up and despatched

Effective date: 20010227

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 39/00 A, 7C 07K 14/705 B, 7C 07K 16/18 B, 7G 01N 33/566 B, 7G 01N 33/68 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020801